Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe displayed site revision changes from v3.7.2 to v3.8.0. The study record history and trial information remain unchanged.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA site-wide NIH banner about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check42 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new revision entry 'Revision: v3.7.0' to the history, representing updated information being posted. The older revision 'Revision: v3.6.6' was removed from the history, altering the set of recorded revisions.SummaryDifference0.1%

- Check77 days agoChange DetectedNew revision v3.6.6 is added to the history, replacing the previous v3.6.5 entry. This reflects an update to the record's version without altering the underlying study data or public-facing content.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page’s revision label updated from v3.6.4 to v3.6.5, indicating a new platform version. No changes to study content or metadata are indicated by this update.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.